RETATRUTIDE 30 mg | Research Use Only - Triple GLP-1/GIP/Glucagon Agonist Research Peptide
Retatrutide representa la frontera actual en investigación metabólica. Como agonista triple de los receptores GLP-1, GIP y glucagón, activa tres vías hormonales simultáneamente, amplificando la respuesta del organismo en regulación del apetito, glucosa y metabolismo de las grasas.
Research overview
Retatrutide is studied in metabolic research models involving glucagon, GLP-1, and GIP signaling pathways.
Research areas
- Body-weight research models
- Fatty acid oxidation research
- Glucose regulation research
- Metabolic energy pathway research
Technical specifications
- Concentration: 30 mg per vial
- Form: Lyophilized powder
- Use: Research Use Only
- Storage: Refrigerate between 2–8°C after reconstitution
Research Use Only. Not for human consumption. Information is provided for qualified research contexts and is not medical advice.